Table 1.
Patient | Gender | Age at HTx (years) | Dx at HTx | Interval between HTx and tTLI (months) | Duration of tTLI (days) | Number of tTLI courses | tTLI dose (Gy) | Follow-up (years) |
---|---|---|---|---|---|---|---|---|
1 | Male | 34 | DCMP | 10.7 | 67 | 2 | 4 + 4.8* | 7.0 |
2 | Female | 57 | HOCMP | 36 | 48 | 1 | 6.4 | 5.2 |
3 | Female | 43 | Myocarditis | 2.7 | 3 | 1 | 1.6 | 1.8 |
4 | Male | 19 | CHD | 33.6 | 43 | 1 | 8 | 1.9 |
5 | Male | 47 | DCMP | 1.6 | 27 | 1 | 4.8 | 11.7 |
6 | Female | 62 | CVD | 2.4 | 57 | 2 | 1.6 + 6.4+ | 12.2 |
7 | Male | 55 | CAD | 8.8 | 67 | 1 | 8 | 10.3 |
Abbreviations: HTx = heart transplantation; Dx at HTx = diagnosis leading to heart transplantation; DCMP = dilatative cardiomyopathia; HOCMP = hypertrophic obstructive cardiomyopathia; CHD = congenital heart disease; CVD = cardiac valvular disease; CAD = coronary artery disease; tTLI = tailored total lymphoid irradiation. * Second tTLI was initiated 1.5 months after the first one or 12.5 months after HTx. +Second tTLI was initiated 1 month after the first one or 3.5 months after HTx.